Transplantation of blood stem cells (haematopoietic stem cell transplantation) is an important treatment option for patients with haematopoietic disorders. This method is also applied in hematopoietic stem cell-directed gene therapy. Researchers from the Paul-Ehrlich-Institut (PEI), Federal Institute for Vaccines and Biomedicines identified the endothelial protein-C receptor (EPCR) on hematopoietic stem cells to improve stem cell transplantation. These research results are reported in the journal Blood in its online version of 25.01.2019.
Blood cells are constantly renewed – platelets for instance have a life time of a few days and red blood cells between one and three months. These blood cells derive from blood stem cells (haematopoietic stem cells) residing in the bone marrow and differentiating into all different blood cell types.
They can self-renew and switch to quiescence to protect themselves against exhaustion caused by frequent cell division. When the process of differentiation, self-renewal, and quiescence is disturbed, blood cell disorders can develop.
This can be the case, for instance, in blood cell diseases such as leukemia or aplastic anaemia, which, in the event of loss of blood stem cells, lead to a blood cell deficiency. A possible therapy option by aplastic anaemia is the transplantation of blood stem cells from suitable donors (haematopoietic stem cell transplantation).
Which factors will affect the success of this treatment? This question was asked by Professor Ute Modlich, head of the research group "Gene Modification in Stem Cells" at the PEI and her co-workers. For this purpose, she used a mouse model of aplastic anaemia.
In the mice, the central signal pathway of the cytokine thrombopoietin (Thpo) is blocked by deleting its receptor Mpl (myeloproliferative leukaemia virus oncogene, Mpl-deficient mice).
These mice mimic the phenotype of patients with aplastic anaemia caused by inactivating mutations in the same pathway. Blood stem cells of Mpl-deficient mice engraft and expand only very poorly after transplantation.
The Mpl receptor activates various pathways. Which pathway is important for the stem cell preserving function of Thpo/Mpl? To find the answer, researchers expressed potential Thpo-target genes with lentiviral vectors in Mpl-deficient blood stem cells. These cells were transplanted into Mpl-deficient recipient mice and hematopoietic recovery evaluated.
Of the five candidate genes studied, the surface protein EPCR (endothelial protein-C receptor) proved to be an important player: Was this surface protein present on blood stem cells, they expanded and could also transition into quiescence.
In mice which received these modified stem cells (Epcr+Mpl-deficient), a large number of donor cells could be detected in the bone marrow appropriately fast. In further experiments, the PEI researchers proved that Epcr marked the engrafting blood stem cells also in normal haematopoiesis and that they expanded well after stem cell transplantation.
Epcr is known as co-receptor for the protease-activated receptor (PAR1) on endothelial cells. This receptor can be activated by its ligand, activated protein C (aPC). Professor Modlich explained the significance of these research results by stating “We have identified a target structure which we may be able to use to support blood stem cell transplantations. This could be useful in particular in gene therapy where blood stem cells are genetically modified in culture before these cells are transplanted.”
The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.
Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute.
The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).
Kohlscheen S, Schenk F, Rommel M, Cullmann K, Modlich U (2019): Endothelial protein C receptor supports hematopoietic stem cell engraftment and expansion in Mpl-deficient mice.
Blood 133 Jan [Epub ahead of print].
http://www.bloodjournal.org/content/early/2019/01/25/blood-2018-03-837344?sso-ch... - Abstract
https://www.pei.de/EN/information/journalists-press/press-releases/2019/01-surfa... - this press release on the PEI Website
Dr. Susanne Stöcker | idw - Informationsdienst Wissenschaft
Ceramic technologies for highly efficient power-to-X processes
10.10.2019 | Fraunhofer-Institut für Keramische Technologien und Systeme IKTS
Growing and moving
10.10.2019 | University of Freiburg
Superconductivity has fascinated scientists for many years since it offers the potential to revolutionize current technologies. Materials only become superconductors - meaning that electrons can travel in them with no resistance - at very low temperatures. These days, this unique zero resistance superconductivity is commonly found in a number of technologies, such as magnetic resonance imaging (MRI).
Future technologies, however, will harness the total synchrony of electronic behavior in superconductors - a property called the phase. There is currently a...
How do some neutron stars become the strongest magnets in the Universe? A German-British team of astrophysicists has found a possible answer to the question of how these so-called magnetars form. Researchers from Heidelberg, Garching, and Oxford used large computer simulations to demonstrate how the merger of two stars creates strong magnetic fields. If such stars explode in supernovae, magnetars could result.
How Do the Strongest Magnets in the Universe Form?
A hot, molten Earth would be around 5% larger than its solid counterpart. This is the result of a study led by researchers at the University of Bern. The difference between molten and solid rocky planets is important for the search of Earth-like worlds beyond our Solar System and the understanding of Earth itself.
Rocky exoplanets that are around Earth-size are comparatively small, which makes them incredibly difficult to detect and characterise using telescopes. What...
Scientists at the Max Planck Institute for Chemical Physics of Solids in Dresden, Princeton University, the University of Illinois at Urbana-Champaign, and the University of the Chinese Academy of Sciences have spotted a famously elusive particle: The axion – first predicted 42 years ago as an elementary particle in extensions of the standard model of particle physics.
The team found signatures of axion particles composed of Weyl-type electrons (Weyl fermions) in the correlated Weyl semimetal (TaSe₄)₂I. At room temperature,...
The two baby stars were found in the [BHB2007] 11 system - the youngest member of a small stellar cluster in the Barnard 59 dark nebula, which is part of the...
02.10.2019 | Event News
02.10.2019 | Event News
19.09.2019 | Event News
11.10.2019 | Physics and Astronomy
11.10.2019 | Power and Electrical Engineering
11.10.2019 | Power and Electrical Engineering